Mirador Capital Partners LP Acquires New Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Mirador Capital Partners LP bought a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund bought 3,623 shares of the exchange traded fund’s stock, valued at approximately $358,000.

A number of other institutional investors have also recently made changes to their positions in the stock. Park Avenue Securities LLC lifted its holdings in SPDR S&P Biotech ETF by 1,215.5% in the third quarter. Park Avenue Securities LLC now owns 46,989 shares of the exchange traded fund’s stock valued at $4,642,000 after buying an additional 43,417 shares during the period. M&R Capital Management Inc. lifted its stake in shares of SPDR S&P Biotech ETF by 25.1% in the 3rd quarter. M&R Capital Management Inc. now owns 1,501 shares of the exchange traded fund’s stock valued at $148,000 after purchasing an additional 301 shares during the period. Newbridge Financial Services Group Inc. lifted its stake in shares of SPDR S&P Biotech ETF by 3.4% in the 2nd quarter. Newbridge Financial Services Group Inc. now owns 12,600 shares of the exchange traded fund’s stock valued at $1,168,000 after purchasing an additional 419 shares during the period. Sanctuary Advisors LLC bought a new stake in shares of SPDR S&P Biotech ETF during the 2nd quarter valued at about $1,247,000. Finally, LHM Inc. grew its stake in SPDR S&P Biotech ETF by 106.5% during the second quarter. LHM Inc. now owns 77,242 shares of the exchange traded fund’s stock worth $7,161,000 after purchasing an additional 39,828 shares during the period.

SPDR S&P Biotech ETF Stock Up 0.9 %

Shares of NYSEARCA XBI opened at $97.51 on Friday. SPDR S&P Biotech ETF has a 12-month low of $63.80 and a 12-month high of $103.52. The firm has a market cap of $7.43 billion, a PE ratio of 11.47 and a beta of 1.11. The company’s fifty day simple moving average is $98.72 and its 200 day simple moving average is $94.07.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.